Performance-based managed entry agreements for new medicines in OECD countries and EU member states : how they work and possible improvements going forward

Martin Wenzl, Suzannah Chapman

This paper presents findings of an OECD review of managed entry agreements in OECD countries and EU member states conducted in 2018 and 2019. Findings are based on discussions with the OECD Expert Group on Pharmaceuticals and Medical Devices, responses by experts from 12 OECD countries to a survey and semi-structured interviews, and on the literature as well as information published by national authorities responsible for coverage and pricing of medicines.

MoreLess

Year of publication:	2019
Authors:	Wenzl, Martin ; Chapman, Suzannah
Publisher:	[Paris] : OECD

Online Resource

Check full text access |

More access options

doi.org

Check Google Scholar

In German libraries (KVK)

I need help

Extent:	1 Online-Ressource (circa 102 Seiten) Illustrationen
Series:	OECD health working papers. - Paris : [Verlag nicht ermittelbar], ISSN 1815-2015, ZDB-ID 2145281-7. - Vol. no. 115
Type of publication:	Book / Working Paper
Type of publication (narrower categories):	Amtsdruckschrift ; Government document ; Graue Literatur ; Non-commercial literature ; Arbeitspapier ; Working Paper
Language:	English
Notes:	Zusammenfassung in französischer Sprache
Other identifiers:	10.1787/6e5e4c0f-en [DOI]
Classification:	I11 - Analysis of Health Care Markets ; i13 ; H51 - Government Expenditures and Health ; O38 - Government Policy ; O32 - Management of Technological Innovation and R&D
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10012136145